After six women developed a rare disorder involving blood clots within about two weeks of receiving the single dose Johnson & Johnson COVID-19 vaccine, federal health agencies are calling on an immediate pause in using the vaccine.
All six women were between the ages of 18 and 48. One woman died and a second woman in Nebraska is in the hospital in critical condition.
Nearly seven million people in the U-S have received the Johnson & Johnson vaccine, including more than six-thousand people in Springfield during last week’s mega vaccination event at Hammons Student Center.
The FDA says pausing use of the vaccine is out of an abundance of caution, and right now, these adverse affects appear to be extremely rare.